GEN2 NEUROSCIENCE
Gen2 Neuroscience develops therapeutics for the treatment of dementia targeting abnormal forms of the essential cellular protein tau.
GEN2 NEUROSCIENCE
Industry:
Biotechnology Life Science Therapeutics
Founded:
2016-01-01
Address:
Manchester, Manchester, United Kingdom
Country:
United Kingdom
Total Employee:
1+
Status:
Active
Total Funding:
0
Similar Organizations
Alligator Bioscience
Alligator Bioscience develops antibody-based immunotherapies for the treatment of cancer by using its protein optimization technology FIND®.
ATAI Life Sciences
ATAI Life Sciences develops innovative mental health treatments that address significant unmet medical needs.
Galera Therapeutics
Galera Therapeutics develops therapeutic agents for preventing damage to normal tissues during the radiation treatment of cancer.
Current Advisors List
Founder
Investors List
Dementia Discovery Fund
Dementia Discovery Fund investment in Seed Round - Gen2 Neuroscience
More informations about "Gen2 Neuroscience"
Gen2 – drug discovery company
Gen2 Neuroscience Ltd ©2023. ↑See details»
Gen2 Neuroscience - Crunchbase Company Profile & Funding
Where is Gen2 Neuroscience 's headquarters? Gen2 Neuroscience is located in Manchester, Manchester, United Kingdom. Who invested in Gen2 Neuroscience? Gen2 Neuroscience is …See details»
GEN2 NEUROSCIENCE LTD overview - Companies House
Filing history for GEN2 NEUROSCIENCE LTD (09939477) People for GEN2 NEUROSCIENCE LTD (09939477) More for GEN2 NEUROSCIENCE LTD (09939477) Registered office address …See details»
Our Team – Gen2
Scientific Founder and Chief Executive Officer Rick Livesey MD PhD. Chief Operating Officer Emily Scraggs PhD. Chairman Mark Treherne PhDSee details»
Gen2 Neuroscience Ltd. - Drug pipelines, Patents, Clinical trials
Explore Gen2 Neuroscience Ltd. with its drug pipeline, therapeutic area, technology platform, .See details»
Gen2 Company Profile 2024: Valuation, Funding & Investors
Gen2 General Information Description. Developer of dementia drugs designed to identify and target pathological forms of tau. The company's drugs use human-diseased and healthy …See details»
GEN2 NEUROSCIENCE LTD Company Profile - Dun & Bradstreet
Gen2 neuroscience ltd. d&b business directory home / business directory / professional, scientific, and technical services / scientific research and development services / united kingdom / …See details»
Gen2 Neuroscience - Funding, Financials, Valuation & Investors
Jun 3, 2016 Gen2 Neuroscience develops therapeutics for the treatment of dementia targeting abnormal forms of the essential cellular protein tau. Search Crunchbase. ... How much funding …See details»
Gen2 Neuroscience Ltd Company Profile, Financial and ... - digitGaps
Gen2 Neuroscience Ltd develops therapeutics for the treatment of dementia targeting abnormal forms of the essential cellular protein tau. The company was incorporated in 2016 and is …See details»
Gen2 Neuroscience - Crunchbase
Gen2 Neuroscience develops therapeutics for the treatment of dementia targeting abnormal forms of the essential cellular protein tau.See details»
Gen2 Neuroscience | Company | RadialReport
Gen2 Neuroscience is a dementia drug discovery company. They develop therapeutics for the treatment of dementia targeting abnormal forms of the essential cellular protein tau. Their work …See details»
DDF invests in Gen2 Neuroscience Ltd – Dementia Discovery Fund
Jun 3, 2016 About Gen2 Neuroscience Ltd Gen2 is a seed-stage company founded in January 2016 based in Cambridge UK using neuronal platforms (human diseased and healthy neurons …See details»
GEN2 NEUROSCIENCE - VentureRadar
GEN2 NEUROSCIENCE VentureRadar profile. Find out more about GEN2 NEUROSCIENCE including the VentureRadar Innovation and Growth scores, Similar Companies and more.See details»
Gen2 Neuroscience Ltd. - BioCentury Company Profiles - BCIQ
Gen2 Neuroscience Ltd. - BioCentury Company Profiles for the biopharma industrySee details»
Gen2 Neuroscience - Contacts, Employees, Board Members
Gen2 Neuroscience develops therapeutics for the treatment of dementia targeting abnormal forms of the essential cellular protein tau.See details»
Gen2 Neuroscience - CoBee Company Profile & Funding Rounds
Gen2 Neuroscience develops therapeutics for the treatment of dementia targeting abnormal forms of the essential cellular protein tau. Business Model: Revenue: $0. Employees: 1-10. …See details»
Patents Assigned to Gen2 Neuroscience Limited
Jun 29, 2020 Applicant: Gen2 Neuroscience Limited Inventors: Frederick John Livesey, Clare Jones TAU EPITOPE AND BINDING MOLECULES. Publication number: 20220265819 …See details»
Our Science – Gen2 - Gen2 Neuro
Gen2 Neuroscience Ltd ©2023. ↑See details»
GEN2 Table Top Kit V2 - STANDARD by Jerrari - MakerWorld
2 days ago JERRARI3D.com The GEN2 Modular Storage system is a fully functional 3D printable organization ecosystem that was originally designed to be used under any table or …See details»
Gen2 Neuroscience - Tech Stack, Apps, Patents & Trademarks
Organization. Gen2 Neuroscience . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 1. About. …See details»